AtriCure, Inc. (ATRC) stock
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30956% above fair value
$55.39+1.28 (+2.37%)
Close on Nov 20, 2026Market cap $2.82BP/E 263.8Yield –
AtriCure gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
AtriCure's gross profit for the twelve months ending Jun 30, 2026 was $434.61M, up 16.4% year over year. For fiscal 2025 it was $400.78M, up 15.3% from the year before. Over ten years it grew 15.7% a year on average. The highest annual figure on record is $400.78M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $400.78M | +15.3% |
| FY2024 | Dec 31, 2024 | $347.52M | +15.7% |
| FY2023 | Dec 31, 2023 | $300.37M | +22.1% |
| FY2022 | Dec 31, 2022 | $245.94M | +19.5% |
| FY2021 | Dec 31, 2021 | $205.86M | +37.9% |
| FY2020 | Dec 31, 2020 | $149.31M | -12.3% |
| FY2019 | Dec 31, 2019 | $170.34M | +15.8% |
| FY2018 | Dec 31, 2018 | $147.12M | +16.6% |
| FY2017 | Dec 31, 2017 | $126.16M | +13.6% |
| FY2016 | Dec 31, 2016 | $111.10M | +19.6% |
| FY2015 | Dec 31, 2015 | $92.88M | +22.6% |
| FY2014 | Dec 31, 2014 | $75.75M | +27.2% |
| FY2013 | Dec 31, 2013 | $59.56M | +19.1% |
| FY2012 | Dec 31, 2012 | $50.01M | +6.4% |
| FY2011 | Dec 31, 2011 | $47.00M | +3.5% |
| FY2010 | Dec 31, 2010 | $45.39M | +8.6% |
| FY2009 | Dec 31, 2009 | $41.78M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $118.63M | +16.9% |
| Q1 FY2026 | Mar 31, 2026 | $109.31M | +18.0% |
| Q4 FY2025 | Dec 31, 2025 | $105.34M | +13.7% |
| Q3 FY2025 | Sep 30, 2025 | $101.33M | +16.8% |
| Q2 FY2025 | Jun 30, 2025 | $101.48M | +16.9% |
| Q1 FY2025 | Mar 31, 2025 | $92.63M | +14.0% |
| Q4 FY2024 | Dec 31, 2024 | $92.62M | +16.0% |
| Q3 FY2024 | Sep 30, 2024 | $86.79M | +17.5% |
| Q2 FY2024 | Jun 30, 2024 | $86.84M | +12.7% |
| Q1 FY2024 | Mar 31, 2024 | $81.27M | +16.7% |
| Q4 FY2023 | Dec 31, 2023 | $79.82M | +22.6% |
| Q3 FY2023 | Sep 30, 2023 | $73.87M | +19.7% |
| Q2 FY2023 | Jun 30, 2023 | $77.08M | +21.3% |
| Q1 FY2023 | Mar 31, 2023 | $69.61M | +25.2% |
| Q4 FY2022 | Dec 31, 2022 | $65.11M | +18.4% |
| Q3 FY2022 | Sep 30, 2022 | $61.71M | +18.2% |
| Q2 FY2022 | Jun 30, 2022 | $63.52M | +17.5% |
| Q1 FY2022 | Mar 31, 2022 | $55.60M | +24.8% |
| Q4 FY2021 | Dec 31, 2021 | $55.02M | +29.6% |
| Q3 FY2021 | Sep 30, 2021 | $52.23M | +29.5% |
| Q2 FY2021 | Jun 30, 2021 | $54.08M | +95.6% |
| Q1 FY2021 | Mar 31, 2021 | $44.54M | +14.5% |
| Q4 FY2020 | Dec 31, 2020 | $42.44M | -5.2% |
| Q3 FY2020 | Sep 30, 2020 | $40.33M | -3.5% |
| Q2 FY2020 | Jun 30, 2020 | $27.65M | -37.0% |
| Q1 FY2020 | Mar 31, 2020 | $38.88M | -2.5% |
| Q4 FY2019 | Dec 31, 2019 | $44.77M | +16.0% |
| Q3 FY2019 | Sep 30, 2019 | $41.80M | +16.3% |
| Q2 FY2019 | Jun 30, 2019 | $43.89M | +15.3% |
| Q1 FY2019 | Mar 31, 2019 | $39.87M | +15.6% |
| Q4 FY2018 | Dec 31, 2018 | $38.59M | +18.1% |
| Q3 FY2018 | Sep 30, 2018 | $35.95M | +16.3% |
| Q2 FY2018 | Jun 30, 2018 | $38.08M | +17.0% |
| Q1 FY2018 | Mar 31, 2018 | $34.50M | +15.0% |
| Q4 FY2017 | Dec 31, 2017 | $32.68M | +13.1% |
| Q3 FY2017 | Sep 30, 2017 | $30.92M | +12.5% |
| Q2 FY2017 | Jun 30, 2017 | $32.55M | – |
| Q1 FY2017 | Mar 31, 2017 | $30.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $28.90M | – |
| Q3 FY2016 | Sep 30, 2016 | $27.47M | – |
See a number that looks wrong?